Riproximin modulates multiple signaling cascades leading to cytostatic and apoptotic effects in human breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Riproximin modulates multiple signaling cascades leading to cytostatic and apoptotic effects in human breast cancer cells

Published:2015-07-12 Issue:1 Volume:142 Page:135-147
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Pervaiz Asim,Zepp Michael,Adwan Hassan,Berger Martin R.

Funder

Higher Education Commission, Pakistan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-015-2013-3.pdf

Reference59 articles.

1. Adwan H, Bayer H, Pervaiz A, Sagini M, Berger MR (2014a) Riproximin is a recently discovered type II ribosome inactivating protein with potential for treating cancer. Biotechnol Adv 32(6):1077–1090. doi: 10.1016/j.biotechadv.2014.03.008

2. Adwan H, Murtaja A, Kadhim Al-Taee K, Pervaiz A, Hielscher T, Berger MR (2014b) Riproximin’s activity depends on gene expression and sensitizes PDAC cells to TRAIL. Cancer Biol Ther 15(9):1185–1197. doi: 10.4161/cbt.29503

3. Ahn SG et al (2013) Prognostic factors for patients with bone-only metastasis in breast cancer. Yonsei Med J 54(5):1168–1177. doi: 10.3349/ymj.2013.54.5.1168

4. Bagga S, Seth D, Batra JK (2003) The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities. J Biol Chem 278(7):4813–4820. doi: 10.1074/jbc.M207389200

5. Bayer H et al (2012a) Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting. J Biol Chem 287(43):35873–35886. doi: 10.1074/jbc.M112.368548

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation, characterization and evaluation of HPβCD-PTX/PHB nanoparticles for pH-responsive, cytotoxic and apoptotic properties;International Journal of Biological Macromolecules;2024-06

2. Characterization of folic acid-grafted poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles as carriers for sustained release of epirubicin;Journal of Molecular Structure;2024-05

3. The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

4. Anticancer genes (NOXA, PAR-4, TRAIL) are de-regulated in breast cancer patients and can be targeted by using a ribosomal inactivating plant protein (riproximin);Molecular Biology Reports;2023-05-01

5. Apoptotic and antiproliferative effects of silk protein sericin conjugated-AgNO3 nanoparticles in human breast cancer cells;Saudi Journal of Biological Sciences;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3